Invention Application
- Patent Title: 4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZINE AS MODULATORS OF GPR139
-
Application No.: US15382490Application Date: 2016-12-16
-
Publication No.: US20170095480A1Publication Date: 2017-04-06
- Inventor: Stephen Hitchcock , Betty Lam , Holger Monenschein , Holly Reichard
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: US CA San Diego
- Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee Address: US CA San Diego
- Main IPC: A61K31/53
- IPC: A61K31/53
Abstract:
The present invention provides a method for treating a disease, disorder or condition associated with GPR139 using compounds of formula 1: which are agonists of GPR139, certain compounds encompassed by formula 1, pharmaceutical compositions thereof, processes for making the compounds, and intermediates thereof.
Public/Granted literature
- US09770450B2 4-OXO-3,4-dihydro-1,2,3-benzotriazine as modulators of GPR139 Public/Granted day:2017-09-26
Information query
